EUVIMEDObjevte EUVIMED
Crossref

Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity

Ankur Vaidya, Shweta Jain, Banty Kumar, Sanjeev Kumar Sahu, Neeraj Upmanyu, Vivek Asati, Preeti Patel, Vinod Gurjar

ChemistrySelect · 2026-08 · 11 (30)

DOI: 10.1002/slct.74007 ↗

At a glance

Journal article in ChemistrySelect, published online on 2026-08-04. Written by Ankur Vaidya and 7 co-authors. 79 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

As the first member of the receptor tyrosine kinase family, epidermal growth factor (EGFR) has been linked to human cancers through numerous lines of evidence. Research on EGFR has also led to the development of several key theories regarding cancer progression. Through a vast array of paracrine loops, each of which regulates a crucial stage in the metastasis cascade, EGFR not only maintains cell proliferation but also confers resistance to anti‐cancer cytotoxic treatments. To identify EGFR tyrosine kinase inhibitors (TKIs), simulation studies have been used to produce several small molecules, especially those containing quinazolines. The design process also evaluated the emergence of resistance problems and epigenetic changes, which eventually reduced drug efficacy and made it clear that more study in this field was required. The genetic changes taking place in the EGFR tyrosine kinase domain have been thoroughly studied in recent decades. These changes have made it possible to create highly effective inhibitors. The structure–activity relationship (SAR) and cytotoxic activity of several quinazoline derivatives with demonstrated EGFR‐inhibitory antiproliferative activity are highlighted in this review. In the present paper, we report the EGFR‐mediated anticancer potential of quinazoline derivatives discovered after 2020.

Cite

APA

Vaidya, A., Jain, S., Kumar, B., Sahu, S. K., Upmanyu, N., Asati, V., Patel, P., & Gurjar, V. (2026). Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity. ChemistrySelect, 11(30). https://doi.org/10.1002/slct.74007

Vancouver

Vaidya A, Jain S, Kumar B, Sahu SK, Upmanyu N, Asati V, et al. Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity. ChemistrySelect. 2026;11(30). doi:10.1002/slct.74007

BibTeX
@article{Vaidya2026,
  author = {Vaidya, Ankur and Jain, Shweta and Kumar, Banty and Sahu, Sanjeev Kumar and Upmanyu, Neeraj and Asati, Vivek and Patel, Preeti and Gurjar, Vinod},
  title = {Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {30},
  doi = {10.1002/slct.74007}
}
Start for free →